P

Paragon 28 Inc
NYSE:FNA

Watchlist Manager
Paragon 28 Inc
NYSE:FNA
Watchlist
Price: 10.04 USD -3.74% Market Closed
Market Cap: 838.3m USD
Have any thoughts about
Paragon 28 Inc?
Write Note

Paragon 28 Inc
Accrued Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Paragon 28 Inc
Accrued Liabilities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Accrued Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
P
Paragon 28 Inc
NYSE:FNA
Accrued Liabilities
$28.3m
CAGR 3-Years
41%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Becton Dickinson and Co
NYSE:BDX
Accrued Liabilities
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Boston Scientific Corp
NYSE:BSX
Accrued Liabilities
$2.3B
CAGR 3-Years
4%
CAGR 5-Years
7%
CAGR 10-Years
7%
Stryker Corp
NYSE:SYK
Accrued Liabilities
$3.5B
CAGR 3-Years
6%
CAGR 5-Years
7%
CAGR 10-Years
3%
Abbott Laboratories
NYSE:ABT
Accrued Liabilities
$6.5B
CAGR 3-Years
-1%
CAGR 5-Years
4%
CAGR 10-Years
6%
Intuitive Surgical Inc
NASDAQ:ISRG
Accrued Liabilities
$867.5m
CAGR 3-Years
21%
CAGR 5-Years
13%
CAGR 10-Years
15%
No Stocks Found

Paragon 28 Inc
Glance View

Market Cap
839.3m USD
Industry
Health Care

Paragon 28, Inc. engages in operation of an orthopedic foot and ankle company. The company is headquartered in Englewood, Colorado and currently employs 343 full-time employees. The company went IPO on 2021-10-15. The firm develops, distributes and markets medical devices in the foot and ankle segment of the orthopedic implant marketplace. The firm has developed a range of foot and ankle surgical systems and procedural techniques designed to address the primary conditions requiring treatment in the foot and ankle including fracture fixation, hallux valgus bunions, hammertoe, ankle, progressive collapsing foot deformity (PCFD) or flatfoot, Charcot foot, and orthobiologics. The products used in foot and ankle procedures include screws, wires and pins, plates, nails, fixators, staples, joint implants, soft tissue implants, orthobiologics and other implantation instruments and disposables. The firm has developed approximately 6,600 implant, 1,200 instrument, and 900 disposable and other stock keeping units (SKU’s). The company has commercial footprint across United States and International.

FNA Intrinsic Value
17.14 USD
Undervaluation 41%
Intrinsic Value
Price
P

See Also

What is Paragon 28 Inc's Accrued Liabilities?
Accrued Liabilities
28.3m USD

Based on the financial report for Dec 31, 2023, Paragon 28 Inc's Accrued Liabilities amounts to 28.3m USD.

What is Paragon 28 Inc's Accrued Liabilities growth rate?
Accrued Liabilities CAGR 3Y
41%

Over the last year, the Accrued Liabilities growth was -43%. The average annual Accrued Liabilities growth rates for Paragon 28 Inc have been 41% over the past three years .

Back to Top